The Correlation Between Ovarian Function and Serum Biomarkers
Condition(s) studied
Investigational drug(s) / intervention(s)
blood test: Detection of serum levels of copper ions, iron ions, ceruloplasmin (CP), CuZn SOD, malondialdehyde (MDA), etc. Blood samples will be retained from the rest samples for sex hormones samples for testing sex hormones, which don't increase times of blood collection.
Study summary
The goal of this observational study is to find differences in serum biomarkers between ovarian function and normal individuals.
Eligibility
Primary outcome measure(s)
- copper — On the 2~4th day of menstruation (amenorrhea patients on the enrolled week)
the level of copper in blood sample - Iron ion — On the 2~4th day of menstruation (amenorrhea patients on the enrolled week)
the level of Iron ion in blood sample - ceruloplasmin, CP — On the 2~4th day of menstruation (amenorrhea patientson the enrolled week)
the level of ceruloplasmin in blood sample - CuZn-Superoxide Dismutase, CuZn-SOD/SOD1 — On the 2~4th day of menstruation (amenorrhea patients on the enrolled week)
the level of CuZn-SOD/SOD1 in blood sample - Malondialdehyde,MDA — On the 2~4th day of menstruation (amenorrhea patients on the enrolled week)
the level of MDA in blood sample
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Dongzhimen Hospital, Beijing University of Chinese Medicine | Beijing | China | Recruiting |
More Shi Yun trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06096766 on ClinicalTrials.gov ↗ ← All trials in China